Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
Background/Objective: Tumor necrosis factor-α (TNF-α) antagonists have become increasingly popular in the treatment of psoriasis. However, the increased risk of latent tuberculosis infection (LTBI) reactivation has also become an important issue in clinical practice. The aim of this study was to eva...
Main Authors: | Chun-Yu Cheng, Rosaline Chung-Yee Hui, Sindy Hu, Meng-Heng Hsieh, Yu-Huei Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-09-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S102781171400086X |
Similar Items
-
Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01) -
QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01) -
QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01) -
Diagnostic utility of QuantiFERON-TB gold (QFT-G) in active pulmonary tuberculosis
by: Ahmed Anwar, et al.
Published: (2015-01-01) -
Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON<sup>®</sup> Gold Testing Useful?
by: Jessica Lovatt, et al.
Published: (2021-04-01)